Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Siemens Enters Collaboration Agreement with Pfizer

By LabMedica International staff writers
Posted on 24 Dec 2013
Siemens Healthcare Diagnostics Inc. More...
(Tarrytown, NY, USA) entered into a master collaboration agreement with Pfizer Inc. (New York, NY, USA) to design, develop, and commercialize diagnostic tests for therapeutic products across Pfizer's pipeline. Under the agreement, Siemens will be one of Pfizer's collaboration partners to develop and provide in vitro companion diagnostics. The aim is eventual global commercialization with Pfizer products.

Companion diagnostic tests are clinical tests linked to a specific drug or therapy intended to help physicians make more correct personalized treatment decisions for patients. When used in the drug development process, companion diagnostics may help pharmaceutics companies improve patient selection and treatment monitoring, determine the preferred therapy dosing for patients, and establish a protocol to help maximize the treatment benefit for patients.

The partnership will leverage Siemens' worldwide leadership in providing clinical diagnostic solutions for hospital and reference laboratories, specialty laboratories, and point-of-care (POC) settings (including clinics and physician offices) to help enable diagnostics development.

"Our relationship with Pfizer marks a major milestone in Siemens' personalized medicine strategy," commented Dr. Trevor Hawkins, senior vice president, strategy & innovations, diagnostics division, Siemens Healthcare. John Hubbard, senior vice president and worldwide head of development operations at Pfizer emphasized that, "Companion diagnostics are an important enabler of targeted therapies for patients."

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a leader in medical imaging, laboratory diagnostics, medical information technology, and hearing aids. Siemens offers its customers products and solutions for patient care from a single source, from prevention and early detection, to diagnosis, and finally treatment and aftercare.

Related Links:

Siemens Healthcare Diagnostics Inc.
Pfizer Inc.



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.